DK170414B1 - Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af farmaceutiske præparater - Google Patents

Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af farmaceutiske præparater Download PDF

Info

Publication number
DK170414B1
DK170414B1 DK200289A DK200289A DK170414B1 DK 170414 B1 DK170414 B1 DK 170414B1 DK 200289 A DK200289 A DK 200289A DK 200289 A DK200289 A DK 200289A DK 170414 B1 DK170414 B1 DK 170414B1
Authority
DK
Denmark
Prior art keywords
carbon atoms
alkyl
compound
use according
independently
Prior art date
Application number
DK200289A
Other languages
Danish (da)
English (en)
Other versions
DK200289A (da
DK200289D0 (da
Inventor
Neil Richard Ackerman
Bruce Donald Jaffee
Scott Edward Loveless
Russell Howard Neubauer
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of DK200289D0 publication Critical patent/DK200289D0/da
Publication of DK200289A publication Critical patent/DK200289A/da
Application granted granted Critical
Publication of DK170414B1 publication Critical patent/DK170414B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK200289A 1988-04-26 1989-04-25 Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af farmaceutiske præparater DK170414B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18624388 1988-04-26
US07/186,243 US4968701A (en) 1988-04-26 1988-04-26 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents

Publications (3)

Publication Number Publication Date
DK200289D0 DK200289D0 (da) 1989-04-25
DK200289A DK200289A (da) 1989-10-27
DK170414B1 true DK170414B1 (da) 1995-08-28

Family

ID=22684181

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200289A DK170414B1 (da) 1988-04-26 1989-04-25 Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af farmaceutiske præparater

Country Status (13)

Country Link
US (1) US4968701A (pt)
EP (1) EP0339485B1 (pt)
JP (1) JP2650757B2 (pt)
KR (1) KR0134376B1 (pt)
AT (1) ATE87480T1 (pt)
CA (1) CA1333155C (pt)
DE (1) DE68905642T2 (pt)
DK (1) DK170414B1 (pt)
IE (1) IE64760B1 (pt)
IL (1) IL90055A (pt)
MY (1) MY106038A (pt)
PT (1) PT90363B (pt)
ZA (1) ZA893087B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
MX9200299A (es) * 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
US6004979A (en) * 1991-02-07 1999-12-21 Hoechst Marion Roussel Nitrogenous bicycles
US6194376B1 (en) 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
EP0830133A1 (en) * 1995-04-28 1998-03-25 Takeda Chemical Industries, Ltd. Therapeutic composition for arthritis
AU2896097A (en) * 1996-05-10 1997-12-05 Novartis Ag Use of brequinar and derivatives in chronic rejection of allografts and xenotransplantation
ES2173391T3 (es) * 1996-08-16 2002-10-16 Pfizer Derivados de 2-aminobenzazepina y su uso para el tratamiento de la inmunodepresion.
AU757059B2 (en) 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU2108099A (en) * 1998-01-30 1999-08-16 Procept, Inc. Immunosuppressive agents
DK2160950T3 (da) 2004-09-27 2015-06-08 Novozymes As Enzymgranuler
TN2016000197A1 (en) 2013-11-22 2017-10-06 Genzyme Corp Novel methods for treating neurodegenerative diseases.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6592M (pt) * 1967-10-31 1968-12-30
GB1334705A (en) * 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
CH576445A5 (pt) * 1972-03-10 1976-06-15 Ciba Geigy Ag
US4407803A (en) * 1981-08-17 1983-10-04 Abbott Laboratories Antiinflammatory 1-(quinolinyl)-2-pyrazoline derivatives
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4847381A (en) * 1987-08-31 1989-07-11 American Cyanamid Company 2-Phenyl-4-quinoline carboxylic acids

Also Published As

Publication number Publication date
PT90363B (pt) 1994-08-31
KR900016137A (ko) 1990-11-12
DK200289A (da) 1989-10-27
PT90363A (pt) 1989-11-10
IE891328L (en) 1989-10-26
EP0339485B1 (en) 1993-03-31
IL90055A (en) 1993-05-13
ZA893087B (en) 1990-12-28
DE68905642D1 (de) 1993-05-06
DK200289D0 (da) 1989-04-25
CA1333155C (en) 1994-11-22
MY106038A (en) 1994-03-31
ATE87480T1 (de) 1993-04-15
AU628045B2 (en) 1992-09-10
DE68905642T2 (de) 1993-08-12
KR0134376B1 (ko) 1998-04-21
AU3332189A (en) 1989-11-02
IL90055A0 (en) 1989-12-15
JPH01313428A (ja) 1989-12-18
IE64760B1 (en) 1995-09-06
JP2650757B2 (ja) 1997-09-03
US4968701A (en) 1990-11-06
EP0339485A1 (en) 1989-11-02

Similar Documents

Publication Publication Date Title
DK170414B1 (da) Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af farmaceutiske præparater
ES2293993T3 (es) Inhibidores de produccion de tnf-alfa.
US7183285B2 (en) Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
CN103533833A (zh) 降脂抗糖尿病剂
EP2012828A2 (en) Compositions and methods for the treatment of cardiovascular disease
WO1997009977A1 (fr) Inhibiteur specifique de cyclo-oxygenase 2 et agent anti-inflammatoire
JPS6197228A (ja) ジヒドロピリジン類とａｃｅ阻害剤との配合物
US7163945B2 (en) Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
DK169607B1 (da) Anvendelse af acyloxyalkanoylcholinsalt til fremstilling af lægemiddel til behandling af neuropsykiatriske tilstande, såsom demens
WO1996004914A1 (fr) Derive de triazine et medicament
CN115160299A (zh) 一类黄嘌呤氧化酶抑制剂
JP5710480B2 (ja) ペルオキシソーム増殖物質活性化受容体サブタイプδに対するアゴニスト作用を有する化合物、その調製方法及びその使用
US8853259B2 (en) Metformin derivatives for treating diabetes and diabetes complications
US5084462A (en) 4-quinoline carboxylic acid derivatives useful as immunosuppressive agents
US20140329839A1 (en) New Crystalline Form of Pemirolast
CA2347939C (en) Composition for the treatment of rheumatism, hepatitis or pancreatitis
RU2213577C2 (ru) Фармацевтический препарат
US20070021427A1 (en) Novel tricyclic derivatives and their use
CA2772907C (en) Selective antibacterials for clostridium difficile infections
WO1992007833A1 (en) Novel dihydroquinoline derivatives, pharmaceutical compositions and methods of use of dihidroquinoline derivatives as modulators of the arachidonic acid cascade
JP2002293745A (ja) 慢性関節リウマチ治療剤
CA2069313A1 (en) Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
US11987563B1 (en) 3-cyano 4,5-diphenyl furan-2-carboxamides as antitubercular agents
JPS58170756A (ja) スルフアミル安息香酸類の製法
JPS6026370B2 (ja) 制癌剤

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed